Symbols / NBTX Stock $45.49 +6.76% Nanobiotix S.A.

Healthcare • Biotechnology • France • NMS
NBTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Laurent Levy Ph.D.
Exch · Country NMS · France
Market Cap 2.21B
Enterprise Value 2.24B
Income -23.96M
Sales 32.59M
FCF (ttm) -7.89M
Book/sh -2.04
Cash/sh 1.09
Employees 100
Insider 10d —
IPO Dec 11, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 308.32
PEG —
P/S 67.69
P/B -22.26
P/C —
EV/EBITDA -213.91
EV/Sales 68.84
Quick Ratio 1.05
Current Ratio 1.09
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -0.59
EPS next Y 0.15
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-31
Earnings (prior) 2026-03-31
ROA -10.06%
ROE —
ROIC —
Gross Margin 100.00%
Oper. Margin -196.42%
Profit Margin -73.52%
Shs Outstand 48.50M
Shs Float 31.07M
Insider Own 0.00%
Instit Own 11.79%
Short Float 0.03%
Short Ratio 0.16
Short Interest 11.23K
52W High 45.59
vs 52W High -0.23%
52W Low 3.33
vs 52W Low 1,266.07%
Beta 0.58
Impl. Vol. —
Rel Volume 0.82
Avg Volume 68.34K
Volume 56.24K
Target (mean) $34.23
Tgt Median $36.55
Tgt Low $25.90
Tgt High $38.91
# Analysts 6
Recom Strong_buy
Prev Close $42.61
Price $45.49
Change 6.76%
About

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$34.23
Mean price target
2. Current target
$45.49
Latest analyst target
3. DCF / Fair value
$-2.93
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$45.49
Low
$25.90
High
$38.91
Mean
$34.23

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-01 main UBS Neutral → Neutral $30
2026-04-02 main Guggenheim Buy → Buy $36
2026-02-06 main Guggenheim Buy → Buy $26
2025-04-04 main Guggenheim Buy → Buy $8
2024-08-28 init Guggenheim — → Buy $12
2023-12-08 init Leerink Partners — → Outperform $11
2021-01-06 init Evercore ISI Group — → Outperform —
News
RSS: Latest NBTX news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
29.64
+355.32%
-11.61
-138.63%
30.06
0.00
Operating Revenue
22.68
+229.36%
-17.53
-158.94%
29.75
0.00
Operating Expense
40.46
-28.74%
56.78
-0.10%
56.84
+21.70%
46.70
Research And Development
23.11
-42.98%
40.54
+5.59%
38.40
+17.65%
32.64
Selling General And Administration
20.22
+0.81%
20.06
-7.40%
21.66
+23.92%
17.48
General And Administrative Expense
20.22
+0.81%
20.06
-7.40%
21.66
+23.92%
17.48
Salaries And Wages
12.23
+2.00%
11.99
+1.82%
11.77
+21.51%
9.69
Other Gand A
8.00
-0.95%
8.07
-18.36%
9.89
+26.91%
7.79
Other Operating Expenses
-0.40
+51.73%
-0.84
-286.83%
0.45
+30.61%
0.34
Total Expenses
40.46
-28.74%
56.78
-0.10%
56.84
+21.70%
46.70
Operating Income
-10.82
+84.18%
-68.39
-155.40%
-26.78
+42.66%
-46.70
Total Operating Income As Reported
2.09
+103.06%
-68.39
-155.39%
-26.78
+42.66%
-46.70
EBITDA
-12.07
+79.31%
-58.33
-93.87%
-30.09
+39.46%
-49.70
Normalized EBITDA
-8.83
+85.59%
-61.31
-158.01%
-23.76
+54.13%
-51.80
Reconciled Depreciation
1.50
-7.77%
1.62
+7.14%
1.51
+0.87%
1.50
EBIT
-13.56
+77.37%
-59.95
-89.71%
-31.60
+38.28%
-51.20
Total Unusual Items
-3.23
-208.34%
2.98
+147.22%
-6.32
-400.19%
2.11
Total Unusual Items Excluding Goodwill
-3.23
-208.34%
2.98
+147.22%
-6.32
-400.19%
2.11
Special Income Charges
—
—
0.00
0.00
Net Income
-23.96
+64.83%
-68.13
-71.62%
-39.70
+30.40%
-57.04
Pretax Income
-23.96
+64.78%
-68.03
-71.88%
-39.58
+30.60%
-57.03
Net Non Operating Interest Income Expense
-9.91
-277.37%
-2.62
+59.49%
-6.48
+47.89%
-12.44
Interest Expense Non Operating
10.39
+28.56%
8.09
+1.30%
7.98
+36.75%
5.84
Net Interest Income
-9.91
-277.37%
-2.62
+59.49%
-6.48
+47.89%
-12.44
Interest Expense
10.39
+28.56%
8.09
+1.30%
7.98
+36.75%
5.84
Interest Income Non Operating
0.98
-62.53%
2.63
+116.02%
1.22
+375.39%
0.26
Interest Income
0.98
-62.53%
2.63
+116.02%
1.22
+375.39%
0.26
Other Income Expense
-3.23
-208.34%
2.98
+147.22%
-6.32
-400.19%
2.11
Gain On Sale Of Security
-3.23
-208.34%
2.98
+147.22%
-6.32
-400.19%
2.11
Tax Provision
0.00
-97.03%
0.10
-15.83%
0.12
+1100.00%
0.01
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-0.81
-208.34%
0.75
+147.22%
-1.58
-400.19%
0.53
Net Income Including Noncontrolling Interests
-23.96
+64.83%
-68.13
-71.62%
-39.70
+30.40%
-57.04
Net Income From Continuing Operation Net Minority Interest
-23.96
+64.83%
-68.13
-71.62%
-39.70
+30.40%
-57.04
Net Income From Continuing And Discontinued Operation
-23.96
+64.83%
-68.13
-71.62%
-39.70
+30.40%
-57.04
Net Income Continuous Operations
-23.96
+64.83%
-68.13
-71.62%
-39.70
+30.40%
-57.04
Normalized Income
-21.54
+69.40%
-70.37
-101.30%
-34.96
+40.36%
-58.62
Net Income Common Stockholders
-23.96
+64.83%
-68.13
-71.62%
-39.70
+30.40%
-57.04
Diluted EPS
-0.50
+65.28%
-1.44
-33.33%
-1.08
+34.15%
-1.64
Basic EPS
-0.50
+65.28%
-1.44
-33.33%
-1.08
+34.15%
-1.64
Basic Average Shares
47.82
+1.17%
47.27
+27.99%
36.93
+6.17%
34.78
Diluted Average Shares
47.82
+1.17%
47.27
+27.99%
36.93
+6.17%
34.78
Diluted NI Availto Com Stockholders
-23.96
+64.83%
-68.13
-71.62%
-39.70
+30.40%
-57.04
Amortization
0.00
+0.00%
0.00
0.00
-100.00%
0.00
Amortization Of Intangibles Income Statement
0.00
+0.00%
0.00
0.00
-100.00%
0.00
Depreciation Amortization Depletion Income Statement
0.34
+8.15%
0.32
+18.15%
0.27
-19.40%
0.34
Depreciation And Amortization In Income Statement
0.34
+8.15%
0.32
+18.15%
0.27
-19.40%
0.34
Depreciation Income Statement
0.34
+8.18%
0.32
+17.78%
0.27
-19.16%
0.33
Other Taxes
-2.82
+14.64%
-3.30
+16.22%
-3.94
+3.72%
-4.09
Rent And Landing Fees
—
—
—
—
Rent Expense Supplemental
—
—
—
—
Total Other Finance Cost
0.50
+117.51%
-2.83
-893.68%
-0.28
-104.16%
6.86
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
67.76
+0.51%
67.42
-28.20%
93.90
+57.10%
59.77
Current Assets
62.75
+2.09%
61.47
-29.62%
87.34
+66.81%
52.36
Cash Cash Equivalents And Short Term Investments
52.75
+6.06%
49.74
-33.93%
75.28
+81.90%
41.39
Cash And Cash Equivalents
52.75
+6.06%
49.74
-33.93%
75.28
+81.90%
41.39
Cash Equivalents
51.94
+16.91%
44.43
0.00
-100.00%
2.81
Cash Financial
0.81
-84.74%
5.31
-92.95%
75.28
+95.16%
38.58
Receivables
7.68
-10.02%
8.54
-10.11%
9.49
+18.87%
7.99
Accounts Receivable
2.14
-28.25%
2.98
+228.95%
0.91
+796.04%
0.10
Other Receivables
1.43
+31.43%
1.08
-68.82%
3.48
+26.96%
2.74
Taxes Receivable
4.12
-7.94%
4.47
-12.47%
5.11
-0.70%
5.15
Prepaid Assets
2.32
-27.45%
3.19
+24.80%
2.56
-14.12%
2.98
Other Current Assets
0.00
+300.00%
-0.00
-200.00%
0.00
+0.00%
0.00
Total Non Current Assets
5.01
-15.81%
5.95
-9.26%
6.56
-11.52%
7.41
Net PPE
4.57
-17.55%
5.54
-11.41%
6.25
-12.21%
7.12
Gross PPE
17.01
+2.71%
16.56
+5.39%
15.71
+2.69%
15.30
Accumulated Depreciation
-12.44
-12.88%
-11.02
-16.49%
-9.46
-15.66%
-8.18
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
9.07
+0.45%
9.03
+2.59%
8.80
+3.97%
8.46
Machinery Furniture Equipment
4.71
+1.33%
4.65
+5.68%
4.40
+0.73%
4.37
Construction In Progress
0.64
+63.94%
0.39
+107.98%
0.19
-45.35%
0.34
Other Properties
2.59
+3.81%
2.49
+7.13%
2.33
+9.45%
2.13
Goodwill And Other Intangible Assets
0.01
+42.86%
0.01
-12.50%
0.01
+700.00%
0.00
Other Intangible Assets
0.01
+42.86%
0.01
-12.50%
0.01
+700.00%
0.00
Investments And Advances
—
—
0.00
0.00
Non Current Prepaid Assets
0.41
+0.74%
0.41
+35.79%
0.30
+2.75%
0.29
Other Non Current Assets
0.03
—
—
—
Total Liabilities Net Minority Interest
152.24
+14.36%
133.12
+39.04%
95.74
+10.28%
86.81
Current Liabilities
57.51
-2.42%
58.94
+18.17%
49.87
+31.47%
37.94
Payables And Accrued Expenses
16.55
-39.98%
27.58
+6.63%
25.86
+56.97%
16.48
Payables
14.01
+16.49%
12.03
-17.02%
14.49
+30.79%
11.08
Accounts Payable
6.58
+46.74%
4.48
-33.02%
6.70
+67.42%
4.00
Other Payable
0.61
-8.78%
0.67
+60.00%
0.42
-13.93%
0.49
Current Accrued Expenses
2.54
-83.66%
15.55
+36.78%
11.37
+110.77%
5.39
Employee Benefits
0.51
+17.36%
0.43
+33.75%
0.32
+19.63%
0.27
Total Tax Payable
6.82
-0.79%
6.87
-6.88%
7.38
+11.89%
6.59
Current Debt And Capital Lease Obligation
4.31
-12.49%
4.92
-1.95%
5.02
+10.13%
4.56
Current Debt
3.10
-15.40%
3.66
-4.19%
3.82
+6.25%
3.60
Other Current Borrowings
3.10
-15.40%
3.66
-4.19%
3.82
+6.25%
3.60
Current Capital Lease Obligation
1.21
-4.04%
1.26
+5.17%
1.20
+24.64%
0.96
Current Deferred Liabilities
36.22
+99.42%
18.16
-0.37%
18.23
+9.99%
16.57
Current Deferred Revenue
36.22
+99.42%
18.16
-0.37%
18.23
+9.99%
16.57
Other Current Liabilities
0.31
-96.02%
7.83
—
—
Total Non Current Liabilities Net Minority Interest
94.74
+27.70%
74.19
+61.74%
45.87
-6.16%
48.88
Long Term Debt And Capital Lease Obligation
91.01
+97.94%
45.98
+0.96%
45.54
-6.31%
48.61
Long Term Debt
89.12
+107.21%
43.01
+3.24%
41.66
-5.40%
44.04
Long Term Capital Lease Obligation
1.89
-36.38%
2.97
-23.54%
3.88
-15.00%
4.57
Non Current Pension And Other Postretirement Benefit Plans
0.51
+17.36%
0.43
+33.75%
0.32
+19.63%
0.27
Other Non Current Liabilities
3.22
-88.41%
27.78
+1388700.00%
0.00
—
Stockholders Equity
-84.48
-28.58%
-65.70
-3463.07%
-1.84
+93.18%
-27.05
Common Stock Equity
-84.48
-28.58%
-65.70
-3463.07%
-1.84
+93.18%
-27.05
Capital Stock
1.45
+2.04%
1.42
+0.64%
1.41
+35.18%
1.05
Common Stock
1.45
+2.04%
1.42
+0.64%
1.41
+35.18%
1.05
Share Issued
48.41
+2.07%
47.43
+0.62%
47.13
+35.15%
34.88
Ordinary Shares Number
48.39
+2.07%
47.40
+0.62%
47.11
+35.17%
34.85
Treasury Shares Number
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Additional Paid In Capital
314.40
+0.53%
312.74
+0.00%
312.74
+22.28%
255.76
Retained Earnings
-23.96
+64.83%
-68.13
-71.62%
-39.70
+30.40%
-57.04
Gains Losses Not Affecting Retained Earnings
-376.14
-20.75%
-311.51
-12.84%
-276.07
-21.84%
-226.58
Treasury Stock
0.23
+0.00%
0.23
+0.00%
0.23
+0.00%
0.23
Other Equity Adjustments
-376.14
-20.75%
-311.51
-12.84%
-276.07
-21.84%
-226.58
Total Equity Gross Minority Interest
-84.48
-28.58%
-65.70
-3463.07%
-1.84
+93.18%
-27.05
Total Capitalization
4.64
+120.44%
-22.69
-157.00%
39.82
+134.28%
17.00
Working Capital
5.24
+107.15%
2.53
-93.24%
37.47
+159.78%
14.42
Invested Capital
7.74
+140.65%
-19.03
-143.61%
43.64
+111.91%
20.59
Total Debt
95.32
+87.26%
50.90
+0.67%
50.56
-4.90%
53.17
Net Debt
39.47
—
—
6.25
Capital Lease Obligations
3.10
-26.74%
4.23
-16.77%
5.08
-8.10%
5.53
Net Tangible Assets
-84.49
-28.58%
-65.71
-3448.06%
-1.85
+93.15%
-27.05
Tangible Book Value
-84.49
-28.58%
-65.71
-3448.06%
-1.85
+93.15%
-27.05
Available For Sale Securities
—
—
—
—
Current Provisions
0.12
-73.06%
0.44
-42.37%
0.76
+132.42%
0.33
Investmentin Financial Assets
—
—
0.00
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-33.42
-70.95%
-19.55
-56.71%
-12.48
+66.37%
-37.10
Cash Flow From Continuing Operating Activities
-33.42
-70.94%
-19.55
-56.70%
-12.48
+66.37%
-37.10
Net Income From Continuing Operations
-23.96
+64.83%
-68.13
-71.62%
-39.70
+30.40%
-57.04
Depreciation Amortization Depletion
1.50
-7.77%
1.62
+7.14%
1.51
+0.87%
1.50
Depreciation And Amortization
1.50
-7.77%
1.62
+7.14%
1.51
+0.87%
1.50
Other Non Cash Items
-10.83
-137.85%
28.61
+138.90%
11.97
-5.40%
12.66
Stock Based Compensation
3.54
-17.66%
4.30
+33.40%
3.22
+1.51%
3.17
Provisionand Write Offof Assets
-0.23
+14.45%
-0.26
-151.98%
0.51
+65.90%
0.30
Deferred Tax
0.00
-97.03%
0.10
-15.83%
0.12
0.00
Deferred Income Tax
0.00
-97.03%
0.10
-15.83%
0.12
0.00
Operating Gains Losses
0.15
+5200.00%
-0.00
+87.50%
-0.02
-900.00%
0.00
Change In Working Capital
-3.40
-123.81%
14.28
+43.98%
9.92
+331.49%
2.30
Change In Receivables
1.85
+421.41%
0.35
+132.57%
-1.09
+40.31%
-1.83
Changes In Account Receivables
0.84
+140.58%
-2.07
-156.82%
-0.81
-698.02%
-0.10
Change In Payables And Accrued Expense
-5.41
-376.21%
1.96
-77.42%
8.68
+198.62%
2.90
Change In Payable
-5.41
-376.21%
1.96
-77.42%
8.68
+198.62%
2.90
Change In Other Working Capital
-0.02
-100.13%
12.19
+656.39%
1.61
—
Change In Other Current Liabilities
0.17
+178.13%
-0.22
-130.98%
0.72
-40.74%
1.22
Investing Cash Flow
-0.58
+39.48%
-0.95
-173.64%
-0.35
-352.90%
0.14
Cash Flow From Continuing Investing Activities
-0.58
+39.48%
-0.95
-173.64%
-0.35
-354.74%
0.14
Net PPE Purchase And Sale
-0.54
+36.41%
-0.85
-157.93%
-0.33
-256.52%
-0.09
Purchase Of PPE
-0.54
+36.41%
-0.85
-157.93%
-0.33
-256.52%
-0.09
Capital Expenditure
-0.55
+35.61%
-0.85
-151.63%
-0.34
-262.37%
-0.09
Net Investment Purchase And Sale
-0.03
+70.09%
-0.11
-791.67%
-0.01
-105.22%
0.23
Purchase Of Investment
—
—
—
—
Net Intangibles Purchase And Sale
-0.01
-300.00%
-0.00
+77.78%
-0.01
-800.00%
-0.00
Purchase Of Intangibles
-0.01
-300.00%
-0.00
+77.78%
-0.01
-800.00%
-0.00
Net Other Investing Changes
—
—
—
0.00
Financing Cash Flow
37.42
+828.65%
-5.13
-110.98%
46.77
+927.66%
-5.65
Cash Flow From Continuing Financing Activities
37.42
+828.67%
-5.13
-110.98%
46.77
+927.81%
-5.65
Net Issuance Payments Of Debt
38.19
+1019.11%
-4.16
-14.94%
-3.62
+23.65%
-4.74
Issuance Of Debt
42.93
0.00
-100.00%
0.15
0.00
Repayment Of Debt
-4.74
-14.18%
-4.16
-10.36%
-3.77
+20.49%
-4.74
Long Term Debt Issuance
42.93
0.00
-100.00%
0.15
0.00
Long Term Debt Payments
-4.74
-14.18%
-4.16
-10.36%
-3.77
+20.49%
-4.74
Net Long Term Debt Issuance
38.19
+1019.11%
-4.16
-14.94%
-3.62
+23.65%
-4.74
Net Common Stock Issuance
1.53
0.00
-100.00%
60.15
0.00
Cash Dividends Paid
0.00
0.00
0.00
0.00
Proceeds From Stock Option Exercised
—
—
0.00
0.00
Net Other Financing Charges
-0.78
—
-2.79
-278900.00%
-0.00
Changes In Cash
3.42
+113.32%
-25.64
-175.53%
33.95
+179.66%
-42.62
Effect Of Exchange Rate Changes
-0.40
-527.66%
0.09
+284.31%
-0.05
-161.45%
0.08
Beginning Cash Position
49.74
-33.93%
75.28
+81.90%
41.39
-50.68%
83.92
End Cash Position
52.75
+6.06%
49.74
-33.93%
75.28
+81.90%
41.39
Free Cash Flow
-33.97
-66.52%
-20.40
-59.21%
-12.81
+65.55%
-37.20
Common Stock Issuance
1.53
0.00
-100.00%
60.15
0.00
Interest Paid CFF
-1.53
-56.12%
-0.98
+85.96%
-6.98
-662.62%
-0.92
Issuance Of Capital Stock
1.53
0.00
-100.00%
60.15
0.00
Taxes Refund Paid
-0.20
-219.35%
-0.06
-785.71%
-0.01
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category